Back to User profile » Dr Donald Nixon
Papers published by Dr Donald Nixon:
Early Canadian Real-World Experience with Brolucizumab in Anti-Vascular Endothelial Growth Factor-Experienced Patients with Neovascular Age-Related Macular Degeneration: A Retrospective Chart Review
Giunta M, Gauvin Meunier LP, Nixon D, Steeves J, Noble J
Clinical Ophthalmology 2022, 16:2885-2894
Published Date: 30 August 2022
Contrast Sensitivity Changes in Center Involving Diabetic Macular Edema Treated with Aflibercept
Nixon DR, Flinn N, Enderlein C
Clinical Ophthalmology 2021, 15:4439-4445
Published Date: 11 November 2021
Visual Function for Driving in Diabetic Macular Edema and Retinal Vein Occlusion Post-Stabilization with Anti-Vascular Endothelial Growth Factor
Nixon DR, Flinn N
Clinical Ophthalmology 2021, 15:1659-1666
Published Date: 20 April 2021
Evaluation of contrast sensitivity and other visual function outcomes in diabetic macular edema patients following treatment switch to aflibercept from ranibizumab
Nixon DR, Flinn NAP
Clinical Ophthalmology 2018, 12:191-197
Published Date: 22 January 2018
Evaluation of contrast sensitivity and other visual function outcomes in neovascular age-related macular degeneration patients after treatment switch to aflibercept from ranibizumab
Nixon DR, Flinn NAP
Clinical Ophthalmology 2017, 11:715-721
Published Date: 18 April 2017
An observational study of bimatoprost 0.01% in patients on prior intraocular pressure-lowering therapy: the Canadian Lumigan® RC Early Analysis Review (CLEAR) trial
Crichton AC, Nixon DR, Simonyi S, Bhogal M, Sigouin CS, Discepola MJ, Hutnik CML, Baptiste DC, Yan DB
Clinical Ophthalmology 2014, 8:1031-1038
Published Date: 23 May 2014
An observational study of bimatoprost 0.01% in treatment-naïve patients with primary open angle glaucoma or ocular hypertension: the CLEAR trial
Nixon DR, Simonyi S, Bhogal M, Sigouin CS, Crichton AC, Discepola M, Hutnik CML, Yan DB
Clinical Ophthalmology 2012, 6:2097-2103
Published Date: 18 December 2012
Twelve-week, randomized, multicenter study comparing a fixed combination of brimonidine-timolol with timolol as therapy adjunctive to latanoprost
Fechtner RD, Harasymowycz P, Nixon DR, Vold SD, Zaman F, Williams JM, Hollander DA
Clinical Ophthalmology 2011, 5:945-953
Published Date: 8 July 2011